643 related articles for article (PubMed ID: 27838190)
1. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
3. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
[TBL] [Abstract][Full Text] [Related]
4. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
[TBL] [Abstract][Full Text] [Related]
5. Treatment of infantile spasms.
Hancock EC; Osborne JP; Edwards SW
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
[TBL] [Abstract][Full Text] [Related]
6. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
[TBL] [Abstract][Full Text] [Related]
7. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.
Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Lux AL; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
Arch Dis Child; 2010 May; 95(5):382-6. PubMed ID: 20457702
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
[TBL] [Abstract][Full Text] [Related]
9. Treatment of infantile spasms.
Hancock EC; Osborne JP; Edwards SW
Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
Carmant L
Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of West syndrome].
Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
[TBL] [Abstract][Full Text] [Related]
12. Treatment of infantile spasms.
Hancock E; Osborne J; Milner P
Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
[TBL] [Abstract][Full Text] [Related]
13. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial.
Elterman RD; Shields WD; Bittman RM; Torri SA; Sagar SM; Collins SD
J Child Neurol; 2010 Nov; 25(11):1340-7. PubMed ID: 20404353
[TBL] [Abstract][Full Text] [Related]
14. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
[TBL] [Abstract][Full Text] [Related]
16. The underlying etiology of infantile spasms (West syndrome): Information from the International Collaborative Infantile Spasms Study (ICISS).
Osborne JP; Edwards SW; Dietrich Alber F; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FJK;
Epilepsia; 2019 Sep; 60(9):1861-1869. PubMed ID: 31418851
[TBL] [Abstract][Full Text] [Related]
17. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms.
Appleton RE; Peters AC; Mumford JP; Shaw DE
Epilepsia; 1999 Nov; 40(11):1627-33. PubMed ID: 10565592
[TBL] [Abstract][Full Text] [Related]
18. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of vigabatrin in patients with infantile spasms.
Elterman RD; Shields WD; Mansfield KA; Nakagawa J;
Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
Ohtsuka Y
Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
